Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if the addition of antiplatelet therapy (i.e. aspirin) to low-molecular-weight-heparin (i.e. enoxaparin) will decrease the incidence of venous thromboembolism...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Miami
NCT07350499 · Arterial Thromboembolism, Venous Thromboembolism, and more
NCT06386003 · Post Traumatic Stress Disorder, PTSD, and more
NCT07082218 · Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury, and more
NCT07175025 · PTSD - Post Traumatic Stress Disorder, PTSD (Childbirth-Related)
NCT07213778 · Symptomatic Venous Thromboembolism (VTE)
Ryder Trauma Center
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions